Moderna vaccine vs new mutations of SARS-CoV-2 virus
Najnowsze badania pokazują, że szczepionka przeciw COVID-19 na bazie mRNA firmy Moderna nadal chroni przed nowymi wariantami wirusa SARS-CoV-2. Naukowcy udowodnili, iż pomimo kilkukrotnej redukcji
What do you need to know about COVID-19 vaccines and the SARS-CoV-2 virus
A team of scientists from PSNC and IBCH PAS has developed a set of Q&A about vaccines against COVID-19 and the SARS-CoV-2 virus as part of the
Herd immunity by infection is not an option
Review paper published in Science clearly demonstrate that achieving herd immunity through infection will be very costly in terms of mortality and morbidity, with little guarantee of success.
Scenarios for 2021 according to COVID-19 team lead by the President of the Polish Academy of Sciences
Opracowanie zawiera hipotetyczne scenariusze rozwoju pandemii COVID-19 w 2021 roku i w latach najbliższych. https://informacje.pan.pl/index.php/informacje/materialy-dla-prasy/3218-stanowisko-9-zespolu-ds-covid-19-przy-prezesie-pan-scenariusze-na-2021-rok
Tracking COVID-19 vaccination rates
Thanks to collaborative efforts between researchers at the University of Oxford and the non-profit organization Global Change Data Lab we can track the number of COVID-19 vaccination doses within a given population including Poland.
Update on new SARS-CoV-2 variant identified in UK
COVID-19 Genomics UK (COG-UK) Consortium, has been created to deliver large-scale and rapid whole-genome virus sequencing to local NHS centres and the UK government. According to COG-UK, at this point in time, there is no reason to believe that any of the new variants of SARS-CoV-2 including VUI-202012/01 will affect vaccine efficacy.